BACTI-B Bactiguard Holding AB (publ)

1.486USD15.10 SEK · STO-2.89%Mkt Cap: 53.15M USDP/E: 68.64

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound…

Key Statistics

Company
Market Cap53.15M USD
Enterprise Value61.80M USD
Revenue (TTM)21.32M USD
Gross Profit18.18M USD
Net Income (TTM)-772.08K USD
Revenue/Share0.61 USD
Last Price1.486 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees166
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0005878741
Valuation
P/E (Trailing)68.64
P/E (Forward)167.78
PEG—
EV/EBITDA16.50
EV/Revenue2.90
P/S2.49
P/B1.69
EPS (TTM)0.02 USD
EPS (Forward)0.0089 USD
52W Range
1.37814% of range2.126
52W High2.126 USD
52W Low1.378 USD
Profitability
Gross Margin85.52%
Oper. Margin3.18%
EBITDA Margin17.56%
Profit Margin-3.63%
ROE-2.49%
ROA-1.44%
ROIC-0.97%
ROCE-1.60%
Growth
Revenue Growth21.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-146.17K USD
CapEx (TTM)563.02K USD
FCF Margin14.04%
FCF Yield5.63%
Net Debt9.71M USD
Net Debt/EBITDA2.59
Net Debt/FCF3.24
Balance Sheet
Debt/Equity0.52
Current Ratio1.88
Quick Ratio1.27
Book Value/Sh0.88 USD
Cash/Share0.15 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.264 USD
Upside (mean)+52.3%
Target Range2.264 USD – 2.264 USD
# Analysts1
Ownership
Shares Out.31.04M
Float13.23M
Insiders37.56%
Institutions37.19%
Technical
SMA 501.543 (-3.7%)
SMA 2001.588 (-6.4%)
Beta0.41
S&P 52W Chg12.00%
Avg Vol (30d)6.01K
Avg Vol (10d)3.25K
Technical Indicators
RSI (14)46.0
MACD-0.1261
MACD Signal-0.1026
MACD Hist.-0.0235
BB Upper1.605 USD
BB Middle1.530 USD
BB Lower1.454 USD
BB Width9.85%
ATR (14)0.0816 USD
Vol Ratio (20d)0.42x

About Bactiguard Holding (STO: BACTI-B)

›

Bactiguard Holding (STO: BACTI-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 166 employees.

The shares were at 15.10 SEK on 19 November 2026, down 10.9% over 52 weeks. Its 52-week range is 14.00 SEK to 21.60 SEK: the price is 30.1% below the high and 7.9% above the low.

At a market capitalisation of 539.96M SEK, it trades at 68.6 times trailing earnings and 167.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 168% for BACTI-B.

Bactiguard Holding reports return on equity of -2.5%, an operating margin of 3.2% and revenue up 21.2% year over year.

Its debt exceeds its cash by 98.70M SEK, a debt-to-equity ratio of 0.52. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 23.00 SEK is 52.3% above the current price. The next earnings report is expected on 4 February 2027.